SBH
QGEN icon

Segall Bryant & Hamill’s Qiagen QGEN Stock Holding History

Segall Bryant & Hamill’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-111,177
Closed -$4.45M – 654
2026
Q1 		$4.45M Sell
111,177
-36,110
-25% -$1.71M 0.06% 314
2025
Q4 		$6.62M Buy
147,287
+2,498
+2% +$116K 0.09% 283
2025
Q3 		$6.47M Sell
144,789
-45,949
-24% -$2.2M 0.09% 292
2025
Q2 		$9.17M Buy
190,738
+15,082
+9% +$656K 0.13% 244
2025
Q1 		$7.05M Buy
175,656
+28,181
+19% +$1.19M 0.11% 268
2024
Q4 		$6.75M Buy
147,475
+10,545
+8% +$472K 0.09% 287
2024
Q3 		$6.42M Buy
136,930
+2,246
+2% +$102K 0.09% 291
2024
Q2 		$5.69M Buy
134,684
+8,868
+7% +$389K 0.1% 265
2024
Q1 		$5.56M Sell
125,816
-9,489
-7% -$432K 0.1% 250
2023
Q4 		$6.23M Buy
135,305
+34,020
+34% +$1.45M 0.12% 246
2023
Q3 		$4.35M Sell
101,285
-35,273
-26% -$1.64M 0.05% 341
2023
Q2 		$6.52M Buy
136,558
+1,854
+1% +$89.4K 0.07% 301
2023
Q1 		$6.56M Buy
+134,704
New +$6.85M 0.07% 300

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Segall Bryant & Hamill's QGEN Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 111,177 shares — an estimated $4.45M sold.

Segall Bryant & Hamill first reported a position in QGEN in Q1 2023 and held it in 13 quarters. The position peaked at $9.17M in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Segall Bryant & Hamill reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Segall Bryant & Hamill sold 111,177 Qiagen shares in Q2 2026, an estimated $4.45M.
  • Segall Bryant & Hamill first reported a position in Qiagen in Q1 2023 and held it in 13 quarters.
  • Segall Bryant & Hamill's Qiagen position peaked at $9.17M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.